Ohad Mazor
Impact in
- Biotechnology top 2%
- Transgenic Plants and Applications
- Immunology top 10%
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Bacillus and Francisella bacterial research 8
- Immunology 19
- Toxin Mechanisms and Immunotoxins 16
- Co-authors
- Yoram Salomon (11 shared papers)Avigdor Scherz (11 shared papers)Chanoch Kronman (17 shared papers)Eran Neumark (6 shared papers)Alexander Brandis (6 shared papers)V. Rosenbach‐Belkin (6 shared papers)Ron Alcalay (24 shared papers)Ofer Cohen (9 shared papers)
In The Last Decade
Ohad Mazor
53 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Biotechnology 213
- Immunology 289
- Pulmonary and Respiratory Medicine 296
- Virology 29
- Biomedical Engineering 243
Countries citing papers authored by Ohad Mazor
This map shows the geographic impact of Ohad Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ohad Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ohad Mazor more than expected).
Fields of papers citing papers by Ohad Mazor
This network shows the impact of papers produced by Ohad Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ohad Mazor. The network helps show where Ohad Mazor may publish in the future.
Co-authors
The 25 scholars most cited alongside Ohad Mazor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 125 | |
| 2 | 2005 | 92 | |
| 3 | 2006 | 55 | |
| 4 | 2014 | 46 | |
| 5 | 2017 | 42 | |
| 6 | 2004 | 42 | |
| 7 | 2016 | 35 | |
| 8 | 2015 | 35 | |
| 9 | 2003 | 34 | |
| 10 | 2016 | 33 | |
| 11 | 2005 | 30 | |
| 12 | 2009 | 28 | |
| 13 | 2006 | 26 | |
| 14 | 2015 | 26 | |
| 15 | 2002 | 25 | |
| 16 | 2005 | 23 | |
| 17 | 2021 | 21 | |
| 18 | 2012 | 21 | |
| 19 | 2008 | 21 | |
| 20 | 2014 | 20 |
About Ohad Mazor
Ohad Mazor is a scholar working on Molecular Biology, Immunology, Biotechnology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (16 papers), Transgenic Plants and Applications (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Photodynamic Therapy Research Studies (8 papers), Bacillus and Francisella bacterial research (8 papers), Nanoplatforms for cancer theranostics (8 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Biotechnology (213 citations), Immunology (289 citations), Pulmonary and Respiratory Medicine (296 citations), Virology (29 citations) and Biomedical Engineering (243 citations). Ohad Mazor has collaborated with scholars based in Israel, Italy and France. Frequent co-authors include Yoram Salomon, Avigdor Scherz, Chanoch Kronman, Eran Neumark, Alexander Brandis, V. Rosenbach‐Belkin, Ron Alcalay, Ofer Cohen, Tamar Sabo and Adva Mechaly. Their work appears in journals such as Photochemistry and Photobiology, Antibodies, Toxins, Analytical Biochemistry and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.